
ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
0:00
1:06:22
ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).
Fler avsnitt från "Journal of the American Society of Nephrology (JASN)"



Missa inte ett avsnitt av “Journal of the American Society of Nephrology (JASN)” och prenumerera på det i GetPodcast-appen.








